Lubrizol Expands Medical Tubing Production Five-Fold for Global Export

India Pharma Outlook Team | Friday, 15 November 2024

 production facility, medical tubing

The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the production of top-notch medical tubing for neurovascular and cardiovascular purposes, including balloon catheters and minimally invasive procedure catheters.

Lubrizol, a company owned by Berkshire Hathaway that specializes in chemicals, has signed a MoU with Polyhose in Chennai to establish a manufacturing plant in Tamil Nadu for producing medical tubing for catheters.

Medical tubing will be made using Lubrizol's advanced medical-grade TPU as well as other thermoplastic polymers, providing biocompatibility, high performance, and patient comfort. The upcoming production plant will adhere to ISO 13485 standards, guaranteeing the safety and quality of medical tubing.

“India serves as a hub for Lubrizol’s innovation and growth, and our ongoing investment highlights our dedication to a local-for-local and local-for-global strategy in India," said Rebecca Liebert, President and CEO, Lubrizol.

"This agreement brings precision manufacturing technology into India – a new business opportunity for the country to serve critical care markets in India and across the globe,” said Bhavana Bindra, Lubrizol’s managing director India, Middle East and Africa.

© 2024 India Pharma Outlook. All Rights Reserved.